글로벌 소분자 무균 주사제 시장 – 2031년까지의 산업 동향 및 예측

보고서 사용자 지정 보고서 사용자 지정 지금 구매 지금 구매 무료 샘플 보고서 무료 샘플 보고서
집 Healthcare Global Small Molecule Sterile Injectable Drug Market
TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

글로벌 소분자 무균 주사제 시장 – 2031년까지의 산업 동향 및 예측

  • Healthcare
  • Upcoming Report
  • Feb 2024
  • Global
  • 350 Pages
  • 테이블 수: 220
  • 그림 수: 60
지금 구매 지금 구매

>글로벌 소분자 무균 주사제 시장, 제품별(바이알 충전, 주사기 충전, 카트리지 충전, 소분자 항생제, 화학 요법제, 국소 및 전신 마취제, 골격근 이완제, 진통제, 항응고제, 항경련제, 항바이러스제, 항히스타민제/항알레르기제 및 기타), 투여 경로(정맥 주사(IV), 근육 주사(IM), 피하 주사(SC)), 적용 분야(종양학, 감염성 질환, 심혈관 질환, 대사 질환, 신경학, 피부과, 비뇨기과, 자가면역 질환, 호흡기 질환, 감염성 질환, 중추신경계 질환, 혈액 질환, 근골격계 질환 및 기타), 최종 사용자(병원, 전문 클리닉, 가정 간병 시설 및 기타), 유통 채널(직접 입찰, 소매 약국, 온라인 약국 및 기타) – 2031년까지의 산업 동향 및 전망.

 소분자 무균 주사제 시장

소분자 무균 주사제 시장 분석 및 규모

소분자 멸균 주사제는 약물을 혈류로 직접 전달하여 빠르고 정확한 치료 효과를 보장하는 데 필수적입니다. 병원과 진료소에서 널리 사용되는 이 약물은 감염, 통증 관리, 중환자 치료와 같은 다양한 상태를 치료하여 응급 및 임상 환경에서 생명을 구하는 개입을 제공합니다.                      

Data Bridge Market Research는 2023년에 1,56,774.14백만 달러였던 글로벌 소분자 무균 주사제 시장이 2031년까지 2,73,421.52백만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 7.2%의 CAGR을 보일 것으로 예상된다고 분석했습니다. 이는 시장 가치를 나타냅니다. 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

소분자 무균 주사제 시장 범위 및 세분화

보고서 메트릭

세부

예측 기간

2024년부터 2031년까지

기준 연도

2023

역사적 연도

2022 (2016-2021년까지 사용자 정의 가능)

양적 단위

매출은 백만 달러, 볼륨은 단위, 가격은 달러로 표시됨

다루는 세그먼트

Product (Vial Filling, Syringe Filling, Cartridge Filling, Small Molecule Antibiotics, Chemotherapy Agents, Local and General Anaesthetics, Skeletal Muscle Relaxants, Analgesics, Anticoagulants, Anticonvulsants, Antivirals, Anti-histamines/ Anti-allergy, and Others), Route of Administration (Intravenous (IV), Intramuscular (IM), and Subcutaneous (SC)), Application (Oncology, Infectious Diseases, Cardiovascular Diseases, Metabolic Diseases, Neurology, Dermatology, Urology, Autoimmune Diseases, Respiratory Disorders, Infectious Diseases, CNS Diseases, Blood Disorders, Musculoskeletal Disorders, and Others), End-Users (Hospitals, Specialty Clinics, Home Care Settings and Others), Distribution Channels (Direct Tender, Retail Pharmacy, Online Pharmacy and Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Gilead Sciences, Inc. (U.S.), BioCryst Pharmaceuticals, Inc.  (U.S.), AstraZeneca (U.K.), Genentech, Inc.  (U.S.), Merck KGaA (Germany), Hikma Pharmaceuticals PLC (U.K.), AbbVie Inc. (U.S.), American Regent, Inc. (U.S.), Amgen Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Teligent. (U.S.), Eisai Co., Ltd. (Japan), Teva Pharmaceutical Industries Ltd. (Israel), Neuren Pharmaceuticals (Australia), Noxopharm (Australia), Amomed Pharma GmbH (Austria), Sanofi (France), Exelixis, Inc. (U.S.), Fresenius Kabi USA (U.S.), Pfizer Inc. (U.S.)

Market Opportunities
  • Demand for Convenience Injectable Drugs for Improved Patient Compliance
  • Increasing Healthcare Needs for Aging Population

Market Definition

Small molecule sterile injectable drugs are pharmaceutical compounds with low molecular weight designed for parenteral administration. These drugs, often in liquid form, are sterile and injected directly into the body, offering rapid absorption and efficacy. They encompass various therapeutic classes and are used for treating a wide range of medical conditions.            

Global Small Molecule Sterile Injectable Drugs Market Dynamics

Drivers

  • Rising Chronic Disease Burden Needs Effective Treatment

The escalating burden of chronic diseases, including diabetes, cardiovascular ailments, and cancer, highlights the need for effective treatments. Small molecule sterile injectable drugs are in high demand as they offer targeted therapy, driving their utilization for managing these conditions and addressing the growing healthcare challenges associated with chronic illnesses.

  • Advancements in Biotechnology Expanding Treatment Options

Technological innovations in biotechnology drive the development of novel small molecule injectables, enhancing efficacy, safety, and targeted delivery. These advancements expand treatment options, fueling market growth by meeting diverse therapeutic needs with more effective and precise pharmaceutical solutions.

Opportunities

  • Demand for Convenience Injectable Drugs for Improved Patient Compliance

The demand for small molecule sterile injectable drugs is propelled by preferences for convenience, rapid onset of action, and improved patient compliance, especially in managing diseases requiring frequent dosing. These factors drive market growth, as injectables offer efficient and effective treatment options for patients.

  • Increasing Healthcare Needs for Aging Population

The growing aging population worldwide drives demand for small molecule sterile injectable drugs tailored to age-related conditions such as osteoporosis and arthritis. This demographic shift fuels market expansion as pharmaceutical companies respond to the increasing healthcare needs of the elderly, offering effective treatments for geriatric health concerns. 

Restraints/Challenges

  • Shortages and Supply Chain Risks Lead to Drug Scarcities

Disruptions such as raw material shortages and production capacity constraints can lead to drug scarcities, impacting patient access to essential medications. Shortages and supply chain risks pose significant challenges in the small molecule sterile injectable drugs market, risking the availability of vital treatments and exacerbating healthcare disparities.  

  • Risk of Contamination in Product

Despite stringent measures, microbial contamination risks persist in small molecule sterile injectable drugs, risking product safety and efficacy. This concern undermines consumer trust, leading to potential product recalls, adverse events, and reputational damage for manufacturers, hindering market confidence and impeding business growth. 

This global small molecule sterile injectable drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global small molecule sterile injectable drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In 2022, The FDA greenlights tremelimumab alongside durvalumab and platinum-based chemotherapy for metastatic non-small cell lung cancer in adults. This approval offers a promising treatment option, reflecting advancements in combating NSCLC and providing hope for improved patient outcomes and enhanced survival rates
  • In 2022, The FDA approves Eli Lilly's Mounjaro (tirzepatide) injection, a novel once-weekly GIP and GLP-1 receptor agonist, to enhance glycemic control in adults with type 2 diabetes. This approval marks a significant milestone in diabetes management, offering a convenient and effective treatment option for patients seeking better glucose regulation
  • In 2021, Novartis revealed that branaplam, a small drug molecule, had entered Phase 2 clinical trials for spinal muscular atrophy, marking a significant advancement in potential treatment options for this debilitating condition
  • In January 2020, Sanofi S.A acquired Syntrox to bolster biotechnological product development for cancer and autoimmune disorders. This strategic acquisition is anticipated to contribute to advancements in therapeutic solutions, potentially fostering growth in the small molecule sterile injectable drugs market by expanding treatment options for various medical conditions

Global Small Molecule Sterile Injectable Drugs Market Scope

The global small molecule sterile injectable drugs market is segmented on the basis of product, route of administration, application, end-users, and distribution channels. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Vial Filling
  • Syringe Filling
  • Cartridge Filling
  • Small Molecule Antibiotics
  • Chemotherapy Agents
  • Local and General Anaesthetics
  • Skeletal Muscle Relaxants
  • Analgesics
  • Anticoagulants
  • Anticonvulsants
  • Antivirals
  • Anti-histamines/ Anti-allergy
  • Others

 Route of Administration

  • Intravenous (IV)
  • Intramuscular (IM)
  • Subcutaneous (SC)

 Application

  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • Metabolic Diseases
  • Neurology
  • Dermatology
  • Urology
  • Autoimmune Diseases
  • Respiratory Disorders
  • Infectious Diseases
  • CNS Diseases
  • Blood Disorders
  • Musculoskeletal Disorders
  • Others

 End-Users

  • Hospitals
  • Specialty Clinics
  • Home Care Settings
  • Others

 Distribution Channels

  • Direct Tender
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Global Small Molecule Sterile Injectable Drugs Market Regional Analysis/Insights

The global small molecule sterile injectable drugs market is analysed and market size insights and trends are provided by country, product, route of administration, application, end-users, and distribution channels as referenced above.

세계 소분자 무균 주사제 시장 보고서에서 다루는 국가는 다음과 같습니다. 북미의 미국, 캐나다 및 멕시코, 유럽의 독일, 프랑스, ​​영국, 네덜란드, 스위스, 벨기에, 러시아, 이탈리아, 스페인, 터키, 유럽의 기타 유럽 국가, 중국, 일본, 인도, 한국, 싱가포르, 말레이시아, 호주, 태국, 인도네시아, 필리핀, 아시아 태평양(APAC)의 기타 아시아 태평양(APAC), 사우디 아라비아, UAE, 남아프리카 공화국, 이집트, 이스라엘, 중동 및 아프리카(MEA)의 일부인 기타 중동 및 아프리카(MEA), 브라질, 아르헨티나, 남아메리카의 일부인 기타 남아메리카.

북미는 소분자 멸균 주사제 시장을 지배할 것으로 예상되며, 바이얼 충전 부문은 2021-2028년 동안 미국에서 가장 높은 성장률을 보일 것으로 예상됩니다. 이러한 성장은 노령 인구 증가에 의해 주도되며, 주사제 약물과 멸균 바이얼 충전 솔루션에 대한 수요를 강조합니다.

유럽은 소분자 무균 주사제 시장을 선도할 것으로 예상되며, 바이얼 충전 부문은 독일에서 우세할 것입니다. 이러한 우세는 기술 발전에 기인하며, 독일의 혁신에 대한 의지와 유럽의 무균 주사제 제조 환경을 형성하는 데 있어서의 중추적 역할을 반영합니다.

아시아 태평양 지역은 소분자 멸균 주사제 시장을 지배할 것으로 예상되며, 중국은 바이얼 충전 부문을 선도할 것입니다. 이 나라는 이러한 약물에 대한 공급업체 수가 가장 많아 이 지역 시장의 성장을 촉진하고 제약 제조의 핵심 기업으로서의 입지를 강화하고 있습니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

의료 인프라 성장 설치 기반 및 신기술 침투

글로벌 소분자 무균 주사제 시장은 또한 모든 국가에 대한 자세한 시장 분석을 제공합니다. 자본 장비에 대한 의료 지출 증가, 글로벌 소분자 무균 주사제 시장을 위한 다양한 종류의 제품 설치 기반, 생명선 곡선을 사용한 기술의 영향, 의료 규제 시나리오의 변화 및 글로벌 소분자 무균 주사제 시장에 미치는 영향. 이 데이터는 2016-2021년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 글로벌 소분자 무균 주사제 시장 점유율 분석

글로벌 소분자 무균 주사제 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 제공된 위의 데이터 포인트는 글로벌 소분자 무균 주사제 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 소분자 무균 주사제 시장에서 활동하는 주요 업체는 다음과 같습니다.

  • 길리드 사이언스 주식회사(미국)
  •  BioCryst Pharmaceuticals, Inc. (미국)
  • 아스트라제네카(영국)
  •  제넨텍 주식회사(미국)
  •  머크 KGaA(독일)
  • 히크마 제약(영국)
  •  AbbVie Inc.(미국)
  •  American Regent, Inc. (미국)
  •  암젠 주식회사(미국)
  •  브리스톨-마이어스 스퀴브 회사(미국)
  •  텔리전트. (미국)
  •  에자이 주식회사(일본)
  •  Teva Pharmaceutical Industries Ltd. (이스라엘)
  •  Neuren Pharmaceuticals(호주)
  •  Noxopharm(호주)
  •  Amomed Pharma GmbH(오스트리아)
  •  사노피(프랑스)
  •  엑셀릭시스 주식회사(미국)
  •  프레제니우스 카비 USA(US)
  •  파이저 주식회사(미국)

SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Sample Image Click on image to enlarge
  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of GLOBAL Small molecule sterile injectable drugs market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. Product LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET end user COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. PREMIUM INSIGHTS
    1. Pestel Analysis
    2. Porter's Analysis
  5. REGULATORY FRAMEWORK
    1. REGULATORY GUIDANCE AS PER U.S. FDA.
    2. REGULATORY SCENARIO FOR EUROPEAN UNION
    3. REGULATORY SCENARIO IN JAPAN
    4. REGULATORY FRAMEWORK IN CHINA
  6. Pipeline analysis
  7. Market Overview
    1. DRIVERS
      1. IncreASing Prevalence of chronic diseaseS
      2. PRODUCT APPROVAl of small molecule
      3. High R&D Investment for small molecule developemnt
      4. Strong pipeline for Small molecule injectable
      5. growth in generic injectables
    2. RESTRAINTS
      1. High LEVEL OF QUALITY AND CARE REQUIRED in the PRODUCTION
      2. High manufacturing and purchasING cost of injectableS
      3. Stringent regulations for facilites and equipments required for small molecules injectable
      4. product recall
    3. OPPORTUNITIES
      1. STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
      2. Growing product launches
      3. Rising per captia income and healthcare expenditure
    4. CHALLENGEs
      1. Lack of accessibility
      2. High Cost of Diagnosis & Treatment
  8. IMPACT OF COVID-19 ON THE Global Small Molecule Sterile Injectable Drugs Market
    1. OVERVIEW AFTERMATH OF COVID-19 AND GOVERNMENT ROLE
    2. IMPACT ON price
    3. impact on demand
    4. IMPACT ON SUPPLY CHAIN
    5. STRATEGIC DECISIONS of Government and MANUFACTURERS
    6. Conclusion
  9. GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY PRODUCT
    1. overview
    2. vial filling
    3. syringe filling
    4. cartridge filling
    5. OTHERS
  10. global SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY application
    1. overview
    2. oncology
    3. infectious diseases
    4. cardiovascular diseases
    5. metabolic diseases
    6. neurology
    7. urology
    8. dermatology
    9. autoimmune diseases
    10. respiratory disorders
    11. others
  11. GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY end user
    1. overview
    2. hospitals
    3. specialty clinics
    4. homecare setting
    5. others
  12. GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY distribution channel
    1. overview
    2. direct tender
    3. retail pharmacy
    4. online pharmacy
    5. others
  13. GLOBAL small molecule sterile injectable drugs market, by REGION
    1. overview
    2. ASIA-PACIFIC
      1. China
      2. Japan
      3. India
      4. Australia
      5. South Korea
      6. Singapore
      7. New Zealand
      8. Thailand
      9. Malaysia
      10. Indonesia
      11. Philippines
      12. Vietnam
      13. Rest of Asia-Pacific
    3. EUROPE
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Netherlands
      7. Russia
      8. Switzerland
      9. Belgium
      10. Turkey
      11. Sweden
      12. Denmark
      13. PolaNd
      14. REST OF Europe
    4. MIDDLE EAST AND AFRICA
      1. South Africa
      2. Saudi Arabia
      3. U.A.E.
      4. Egypt
      5. Israel
      6. Ethiopia
      7. Rest of Middle East & Africa
    5. north america
      1. U.S.
      2. CANADA
      3. mexico
    6. SOUTH AMERICA
      1. Brazil
      2. ARGENTINA
      3. rest of south america
  14. GLOBAL small molecule sterile injectable drugs Market, COMPANY landscape
    1. company share analysis: global
    2. company share analysis: north america
    3. company share analysis: europe
    4. company share analysis: Asia-Pacific
  15. Swot analysis
  16. Company profile
    1. PFIZER INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. SERVICE PORTFOLIO
    2. GILEAD SCIENCES, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. Teva Pharmaceutical Industries Ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    4. Fresenius Kabi USA (Asubsidiary of Fresenius SE & Co. KGaA).
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    5. AbbVie Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. American regent, inc. (a daiichi sankyo group company)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. Amgen Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    8. Amomed Pharma GmbH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    9. Astrazeneca
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    10. biocryst pharmaceuticals, inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    11. Bristol-Myers Squibb Company
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    12. Eisai Co., Ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    13. Exelixis, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    14. Genentech, Inc. (A Subsidiary of F. Hoffmann-La Roche Ltd)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    15. Hikma Pharmaceuticals PLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    16. Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    17. Neuren Pharmaceuticals
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    18. Noxopharm
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    19. Sanofi
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    20. Teligent
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
  17. questionnaire
  18. related reports

표 목록

TABLE 1 Global Small Molecule Sterile Injectable DrugS Market, pipeline analysis

TABLE 2 Number of people with diabetes (Million) among ages 20–79 years

TABLE 3 PER CAPITA AMOUNTS: UNITED STATES (1960–2017 Years)

TABLE 4 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By PRODUCT, 2019-2028 (USD MILLION)

TABLE 5 global vial filling IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 6 globaL syringe filling IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 7 globaL cartridge filling IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 8 globaL others IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 9 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By application, 2019-2028 (USD MILLION)

TABLE 10 global oncology IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 11 global infectious diseases IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 12 global cardiovascular disease IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 13 global metabolic diseases in SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 14 global neurology in SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 15 global urology in SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 16 global dermatology in SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 17 global autoimmune diseases in SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 18 global respiratory disorders in SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 19 global others in SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 20 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By end user, 2019-2028 (USD MILLION)

TABLE 21 GLOBAL hospitals IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 22 global specialty clinics IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 23 global homecare setting IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 24 global others IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 25 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 26 global direct tender IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 27 global retail pharmacy IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 28 global online pharmacy IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 29 global others IN SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 30 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 ASIA-PACIFIC small molecule sterile injectable drugs market, By COUNTRY, 2019-2028 (USD Million)

TABLE 32 Asia-Pacific small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 33 Asia-Pacific small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 34 Asia-Pacific small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 35 Asia-Pacific small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 36 China small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 37 China small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 38 China small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 39 China small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 40 Japan small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 41 Japan small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 42 Japan small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 43 Japan small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 44 India small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 45 India small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 46 India small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 47 India small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 48 Australia small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 49 Australia small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 50 Australia small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 51 Australia small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 52 South Korea small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 53 South Korea small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 54 South Korea small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 55 South Korea small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 56 Singapore small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 57 Singapore small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 58 Singapore small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 59 Singapore small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 60 New Zealand small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 61 New Zealand small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 62 New Zealand small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 63 New Zealand small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 64 Thailand small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 65 Thailand small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 66 Thailand small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 67 Thailand small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 68 Malaysia small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 69 Malaysia small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 70 Malaysia small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 71 Malaysia small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 72 Indonesia small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 73 Indonesia small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 74 Indonesia small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 75 Indonesia small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 76 Philippines small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 77 Philippines small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 78 Philippines small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 79 Philippines small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 80 Vietnam small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 81 Vietnam small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 82 Vietnam small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 83 Vietnam small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 84 Rest of Asia-Pacific small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 85 EUROPE small molecule sterile injectable drugs market, By COUNTRY, 2019-2028 (USD Million)

TABLE 86 Europe small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 87 Europe small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 88 Europe small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 89 Europe small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 90 Germany small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 91 Germany small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 92 Germany small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 93 Germany small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 94 France small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 95 France small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 96 France small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 97 France small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 98 U.K. small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 99 U.K. small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 100 U.K. small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 101 U.K. small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 102 Italy small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 103 Italy small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 104 Italy small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 105 Italy small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 106 Spain small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 107 Spain small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 108 Spain small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 109 Spain small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 110 Netherlands small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 111 Netherlands small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 112 Netherlands small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 113 Netherlands small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 114 Russia small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 115 Russia small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 116 Russia small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 117 Russia small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 118 Switzerland small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 119 Switzerland small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 120 Switzerland small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 121 Switzerland small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 122 Belgium small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 123 Belgium small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 124 Belgium small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 125 Belgium small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 126 Turkey small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 127 Turkey small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 128 Turkey small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 129 Turkey small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 130 Sweden small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 131 Sweden small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 132 Sweden small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 133 Sweden small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 134 Denmark small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 135 Denmark small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 136 Denmark small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 137 Denmark small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 138 POLAND small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 139 POLAND small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 140 POLAND small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 141 POLAND small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 142 REST OF Europe small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 143 MIDDLE EAST AND AFRICA small molecule sterile injectable drugs market, By COUNTRY, 2019-2028 (USD Million)

TABLE 144 Middle East and Africa small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 145 Middle East and Africa small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 146 Middle East and Africa small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 147 Middle East and Africa small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 148 South Africa small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 149 South Africa small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 150 South Africa small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 151 South Africa small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 152 Saudi Arabia small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 153 Saudi Arabia small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 154 Saudi Arabia small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 155 Saudi Arabia small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 156 U.A.E. small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 157 U.A.E. small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 158 U.A.E. small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 159 U.A.E. small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 160 Egypt small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 161 Egypt small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 162 Egypt small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 163 Egypt small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 164 Israel small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 165 Israel small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 166 Israel small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 167 Israel small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 168 Ethiopia small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 169 Ethiopia small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 170 Ethiopia small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 171 Ethiopia small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 172 Rest of Middle East & Africa small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 173 NORTH AMERICA small molecule sterile injectable drugs market, By country, 2019-2028 (USD Million)

TABLE 174 North America small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 175 North America small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 176 North America small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 177 U.S. SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By Product, 2019-2028 (USD Million)

TABLE 178 U.S. small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 179 U.S. small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 180 U.S. small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 181 CANADA SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET, By Product Type, 2019-2028 (USD Million)

TABLE 182 Canada small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 183 Canada small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 184 Canada small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 185 Mexico small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 186 Mexico small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 187 Mexico small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 188 Mexico small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 189 SOUTH AMERICA small molecule sterile injectable drugs market, By COUNTRY, 2021-2028 (USD million)

TABLE 190 SOUTH AMERICA Small molecule sterile injectable drugs Market, By product, 2019-2028 (USD Million)

TABLE 191 South America small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 192 South America small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 193 South America small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 194 Brazil small molecule sterile injectable drugs market, By Product, 2019-2028 (USD Million)

TABLE 195 Brazil small molecule sterile injectable drugs market, By Application, 2019-2028 (USD Million)

TABLE 196 Brazil small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 197 Brazil small molecule sterile injectable drugs market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 198 ARGENTINA Small molecule sterile injectable drugsMarket, By product, 2019-2028 (USD Million)

TABLE 199 ARGENTINA small molecule sterile injectable drugs market, By applicatiob, 2019-2028 (USD Million)

TABLE 200 Argentina small molecule sterile injectable drugs market, By End User, 2019-2028 (USD Million)

TABLE 201 ARGENTINA Small molecule sterile injectable drugsMarket, By Distribution Channel, 2019-2028 (USD Million)

TABLE 202 Rest Of South America small molecule sterile injectable drugs market, By Type, 2019-2028 (USD Million)

그림 목록

FIGURE 1 Global SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: SEGMENTATION

FIGURE 2 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: DATA TRIANGULATION

FIGURE 3 global Small molecule sterile injectable drugs market: DROC ANALYSIS

FIGURE 4 Global Small molecule sterile injectable drugs market: Global VS. REGIONAL MARKET ANALYSIS

FIGURE 5 Global Small molecule sterile injectable drugs market: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL Small molecule sterile injectable drugs market: MULTIVARIATE MODELLING

FIGURE 7 GLOBAL Small molecule sterile injectable drugs market: Product lifeline Curve

FIGURE 8 GLOBAL Small molecule sterile injectable drugs market: INTERVIEW DEMOGRAPHICS

FIGURE 9 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: DBMR MARKET POSITION GRID

FIGURE 10 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 GLOBAL Small molecule sterile injectable drugs market: MARKET End user COVERAGE GRID

FIGURE 12 Global Small molecule sterile injectable drugs market: SEGMENTATION

FIGURE 13 NORTH AMERICA is expected to DOMINATE THE GLOBAL Small molecule sterile injectable drugs market, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 14 THE growing geriatric population is expected to DRIVe THE global Small molecule sterile injectable drugs market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 15 PRODUCT SEGMENT is expected to account for the largest share of the global SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET THE FORECAST PERIOD OF 2021 to 2028

FIGURE 16 Asia-pacific is the fastest-growing market FOR the Global Small molecule sterile injectable drugs MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF Global immunoassays-gamma counter Market

FIGURE 18 The graph below shows the increasing prevalence of chronic diseases in 1995 to forecast 2030 in the U.S.

FIGURE 19 Global Small molecule sterile injectable drugs market: BY Product, 2020

FIGURE 20 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY Product, 2021-2028 (USD MILLION)

FIGURE 21 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY Product, CAGR (2021-2028)

FIGURE 22 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 23 global SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY application, 2020

FIGURE 24 global SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY application, 2021-2028 (USD MILLION)

FIGURE 25 global SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY application, CAGR (2021-2028)

FIGURE 26 global SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY application, LIFELINE CURVE

FIGURE 27 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY end user, 2020

FIGURE 28 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY end user, 2021-2028 (USD MILLION)

FIGURE 29 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY end user, CAGR (2021-2028)

FIGURE 30 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY end user, LIFELINE CURVE

FIGURE 31 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY distribution channel, 2020

FIGURE 32 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY distribution channel, 2021-2028 (USD MILLION)

FIGURE 33 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY distribution channel, CAGR (2021-2028)

FIGURE 34 GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET: BY distribution channel, LIFELINE CURVE

FIGURE 35 Global small molecule sterile injectable drugs market: SNAPSHOT (2020)

FIGURE 36 Global small molecule sterile injectable drugs market: BY REGION (2020)

FIGURE 37 Global small molecule sterile injectable drugs market: BY REGION (2021 & 2028)

FIGURE 38 Global small molecule sterile injectable drugs market: BY REGION (2020 & 2028)

FIGURE 39 Global small molecule sterile injectable drugs market: BY product (2021-2028)

FIGURE 40 ASIA-PACIFIC small molecule sterile injectable drugs market: SNAPSHOT (2020)

FIGURE 41 ASIA-PACIFIC small molecule sterile injectable drugs market: BY COUNTRY (2020)

FIGURE 42 ASIA-PACIFIC small molecule sterile injectable drugs market: BY COUNTRY (2021 & 2028)

FIGURE 43 ASIA-PACIFIC small molecule sterile injectable drugs market: BY COUNTRY (2020 & 2028)

FIGURE 44 ASIA-PACIFIC small molecule sterile injectable drugs market: BY product (2021-2028)

FIGURE 45 EUROPE small molecule sterile injectable drugs market: SNAPSHOT (2020)

FIGURE 46 EUROPE small molecule sterile injectable drugs market: BY COUNTRY (2020)

FIGURE 47 EUROPE small molecule sterile injectable drugs market: BY COUNTRY (2021 & 2028)

FIGURE 48 EUROPE small molecule sterile injectable drugs market: BY COUNTRY (2020 & 2028)

FIGURE 49 EUROPE small molecule sterile injectable drugs market: BY PRODUCT (2021-2028)

FIGURE 50 MIDDLE EAST AND AFRICA small molecule sterile injectable drugs market: SNAPSHOT (2020)

FIGURE 51 MIDDLE EAST AND AFRICA small molecule sterile injectable drugs market: BY COUNTRY (2020)

FIGURE 52 MIDDLE EAST AND AFRICA small molecule sterile injectable drugs market: BY COUNTRY (2021 & 2028)

FIGURE 53 MIDDLE EAST AND AFRICA small molecule sterile injectable drugs market: BY COUNTRY (2020 & 2028)

FIGURE 54 MIDDLE EAST AND AFRICA small molecule sterile injectable drugs market: BY PRODUCT (2021-2028)

FIGURE 55 North AMERICA small molecule sterile injectable drugs market: SNAPSHOT (2020)

FIGURE 56 North AMERICA small molecule sterile injectable drugs market: BY COUNTRY (2020)

FIGURE 57 North AMERICA small molecule sterile injectable drugs market: BY COUNTRY (2021 & 2028)

FIGURE 58 North AMERICA small molecule sterile injectable drugs market: BY COUNTRY (2020 & 2028)

FIGURE 59 North AMERICA small molecule sterile injectable drugs market: BY PRODUCT (2021-2028)

FIGURE 60 SOUTH AMERICA small molecule sterile injectable drugs market: SNAPSHOT (2020)

FIGURE 61 SOUTH AMERICA small molecule sterile injectable drugs market: BY COUNTRY (2020)

FIGURE 62 SOUTH AMERICA small molecule sterile injectable drugs market: BY COUNTRY (2021 & 2028)

FIGURE 63 SOUTH AMERICA small molecule sterile injectable drugs market: BY COUNTRY (2020 & 2028)

FIGURE 64 SOUTH AMERICA small molecule sterile injectable drugs market: BY PRODUCT (2021-2028)

FIGURE 65 Global small molecule sterile injectable drugs Market: company share 2020 (%)

FIGURE 66 North America small molecule sterile injectable drugs Market: company share 2020 (%)

FIGURE 67 EUROPE small molecule sterile injectable drugs Market: company share 2020 (%)

FIGURE 68 ASIA-PACIFIC small molecule sterile injectable drugs Market: company share 2020 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

The Small Molecule Sterile Injectable Drugs Market size will be worth USD 2,73,421.52 million during the forecast period.
The Small Molecule Sterile Injectable Drugs Market growth rate is 7.2% during the forecast period.
Advancements in Biotechnology Expanding Treatment Options & Rising Chronic Disease Burden Needs Effective Treatment are the growth drivers of the Small Molecule Sterile Injectable Drugs Market.
The product, route of administration, application, end-users, and distribution channels are the factors on which the Small Molecule Sterile Injectable Drugs Market research is based.
The major companies in the Small Molecule Sterile Injectable Drugs Market are Gilead Sciences, Inc. (U.S.), BioCryst Pharmaceuticals, Inc. (U.S.), AstraZeneca (U.K.), Genentech, Inc. (U.S.), Merck KGaA (Germany), Hikma Pharmaceuticals PLC (U.K.), AbbVie Inc. (U.S.), American Regent, Inc. (U.S.), Amgen Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Teligent. (U.S.), Eisai Co., Ltd. (Japan), Teva Pharmaceutical Industries Ltd. (Israel), Neuren Pharmaceuticals (Australia), Noxopharm (Australia), Amomed Pharma GmbH (Austria), Sanofi (France), Exelixis, Inc. (U.S.), Fresenius Kabi USA (U.S.), Pfizer Inc. (U.S.).

관련 페이지 탐색

Banner